GSK says tests hint COVID drug fights Omicron
2 years ago
233
Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.
Loading 1 comment...
-
0:51
Reuters
8 hours agoPolice arrest pro-Palestinians protesters LA campus
52341 -
1:36
Reuters
2 years agoBiden says Omicron plan includes free at-home tests
1889 -
2:03
KERO
2 years agoU.S. preparing for Omicron COVID variant
1.89K5 -
0:42
Reuters
2 years agoAustralia urgently tests arrivals amid Omicron concerns
25715 -
15:36
WPTV
2 years agoBiden delivers remarks on Omicron variant of Covid
4714 -
1:48
WCPO
2 years agoInside the NKY lab processing COVID tests
181 -
2:56
Newsy
2 years agoWhere Did The Omicron COVID Variant Come From?
4.66K42 -
2:29
KERO
2 years agoScientists race to learn more about COVID variant Omicron
38 -
2:04
WTMJMilwaukee
2 years agoHospitals nearing capacity in Wisconsin with covid patients, no omicron yet
531 -
6:47
Sideserf Cake Studio
16 hours agoReacting to Viral Cake Videos
11.3K3
